Key patient related factors in the management of inflammatory bowel disease

Allocati, Eleonora and Godman, Brian (2020) Key patient related factors in the management of inflammatory bowel disease. Journal of Medical Economics, 23 (12). pp. 1606-1609. ISSN 1369-6998

[thumbnail of Allocati-Godman-JME-2020-Key-patient-related-factors-in-the-management-of-inflammatory] Text (Allocati-Godman-JME-2020-Key-patient-related-factors-in-the-management-of-inflammatory)
Allocati_Godman_JME_2020_Key_patient_related_factors_in_the_management_of_inflammatory.pdf
Accepted Author Manuscript
Restricted to Repository staff only until 19 November 2021.
Download (489kB) | Request a copy from the Strathclyde author

    Abstract

    Background: Inflammatory Bowel Disease (IBD) is a lifelong illness typically starting during the teen years in patients with an appreciable negative impact on health-related-quality-of-life (HRQoL). However, more needs to be known about the effects of IBD on work productivity, daily activities and HRQoL to guide future decision making including priorities for resource allocation with an increasing prevalence of IBD as well as years with disability. In addition, concerns that indirect costs may not always be considered by payers within reimbursement and funding decisions. Methods: Survey among Austrian patients with IBD using robust instruments. Results and Conclusion: IBD does have a substantial burden reducing HRQoL and work productivity and increasing work absenteeism, with differences between those with ulcerative colitis and Chron’s disease. Productivity reduction was associated with reduced HRQoL. Improved HRQoL should be a focus of future treatments and funding decisions, which is particularly important for patients with IBD. However, indirect costs may not always be a focus among reimbursement authorities.

    • Item type:Article
      ID code:74098
      Dates:
      Date
      Event
      19 November 2020
      Published
      5 October 2020
      Accepted
      Keywords:biologicals, inflammatory bowel disease, health authorities, HRQOL, indirect costs, work productivity, Pharmacy and materia medica, Pharmacology, Toxicology and Pharmaceutics(all)
      Subjects:Medicine > Pharmacy and materia medica
      Department:Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
      Depositing user: Pure Administrator
      Date deposited:06 Oct 2020 08:41
      Last modified:21 May 2021 03:18
      URI:https://strathprints.strath.ac.uk/id/eprint/74098
    CORE (COnnecting REpositories)